Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication
KM Thompson, DA Kalkowska - Expert Review of Vaccines, 2020 - Taylor & Francis
Introduction Over the last 20 years (2000-2019) the partners of the Global Polio Eradication
Initiative (GPEI) invested in the development and application of mathematical models of …
Initiative (GPEI) invested in the development and application of mathematical models of …
[HTML][HTML] Enabling accelerated vaccine roll-out for public health emergencies of international concern (PHEICs): novel oral polio vaccine type 2 (nOPV2) experience
GR Macklin, C Peak, M Eisenhawer, F Kurji, O Mach… - Vaccine, 2023 - Elsevier
To address the evolving risk of circulating vaccine-derived poliovirus type 2 (cVDPV2),
Global Polio Eradication Initiative (GPEI) partners are working closely with countries to …
Global Polio Eradication Initiative (GPEI) partners are working closely with countries to …
Immunogenicity of new primary immunization schedules with inactivated poliovirus vaccine and bivalent oral polio vaccine for the polio endgame: a review
AS Bandyopadhyay, JF Modlin… - Clinical Infectious …, 2018 - academic.oup.com
In May 2016, countries using oral polio vaccine for routine immunization switched from
trivalent oral poliovirus vaccine (tOPV) to bivalent type 1 and 3 OPV (bOPV). This was done …
trivalent oral poliovirus vaccine (tOPV) to bivalent type 1 and 3 OPV (bOPV). This was done …
Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine
T Zhao, J Li, Y Fu, H Ye, X Liu, G Li, X Yang, J Yang - npj Vaccines, 2020 - nature.com
The impact of intestinal microbiota on mucosal antibody response to the polio vaccine is
poorly understood. We examined changes in vaccine-induced intestinal mucosal immunity …
poorly understood. We examined changes in vaccine-induced intestinal mucosal immunity …
The early evolution of oral poliovirus vaccine is shaped by strong positive selection and tight transmission bottlenecks
AL Valesano, M Taniuchi, WJ Fitzsimmons, MO Islam… - Cell host & …, 2021 - cell.com
The emergence of circulating vaccine-derived polioviruses through evolution of the oral
polio vaccine (OPV) poses a significant obstacle to polio eradication. Understanding the …
polio vaccine (OPV) poses a significant obstacle to polio eradication. Understanding the …
Assessing the stability of polio eradication after the withdrawal of oral polio vaccine
The oral polio vaccine (OPV) contains live-attenuated polioviruses that induce immunity by
causing low virulence infections in vaccine recipients and their close contacts. Widespread …
causing low virulence infections in vaccine recipients and their close contacts. Widespread …
From vaccine to pathogen: Modeling Sabin 2 vaccine virus reversion and evolutionary epidemiology in Matlab, Bangladesh
W Wong, J Gauld, M Famulare - Virus Evolution, 2023 - academic.oup.com
The oral poliovirus vaccines (OPVs) are one of the most effective disease eradication tools
in public health. However, the OPV strains are genetically unstable and can cause …
in public health. However, the OPV strains are genetically unstable and can cause …
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?
CA Devaux, P Pontarotti, A Levasseur… - Frontiers in Public …, 2024 - frontiersin.org
The polioviruses (PVs) are mainly transmitted by direct contact with an infected person
through the fecal-oral route and respiratory secretions (or more rarely via contaminated …
through the fecal-oral route and respiratory secretions (or more rarely via contaminated …
Polio: from eradication to systematic, sustained control
► Finally, the challenges of the global transition from OPV to inactivated polio vaccine, of
destroying all OPV stocks, of controlling polio spread from longterm excreters, and of …
destroying all OPV stocks, of controlling polio spread from longterm excreters, and of …
Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label …
H He, Y Wang, X Deng, C Yue, X Tang, Y Li… - The Lancet Infectious …, 2020 - thelancet.com
Background The globally synchronised introduction of inactivated poliovirus vaccine (IPV)
and replacement of trivalent oral poliovirus vaccine (OPV) with bivalent OPV (bOPV) were …
and replacement of trivalent oral poliovirus vaccine (OPV) with bivalent OPV (bOPV) were …